PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
argenx SE (ARGX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

NL0010832176

Sector

Healthcare

IPO Date

May 18, 2017

Highlights

Market Cap

$36.40B

EPS (TTM)

$12.76

PE Ratio

46.72

Total Revenue (TTM)

$2.72B

Gross Profit (TTM)

$1.51B

EBITDA (TTM)

$96.13M

Year Range

$352.77 - $678.21

Target Price

$777.98

Short %

3.90%

Short Ratio

6.59

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
ARGX vs. WM ARGX vs. CSU.TO ARGX vs. SPY ARGX vs. ARES ARGX vs. SCHD ARGX vs. VOO ARGX vs. MSFT ARGX vs. VTSAX ARGX vs. COST ARGX vs. ALGN
Popular comparisons:
ARGX vs. WM ARGX vs. CSU.TO ARGX vs. SPY ARGX vs. ARES ARGX vs. SCHD ARGX vs. VOO ARGX vs. MSFT ARGX vs. VTSAX ARGX vs. COST ARGX vs. ALGN

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in argenx SE, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%2,000.00%2,500.00%3,000.00%NovemberDecember2025FebruaryMarchApril
2,492.17%
123.30%
ARGX (argenx SE)
Benchmark (^GSPC)

Returns By Period

argenx SE had a return of -3.06% year-to-date (YTD) and 66.35% in the last 12 months.


ARGX

YTD

-3.06%

1M

-3.83%

6M

5.52%

1Y

66.35%

5Y*

33.04%

10Y*

N/A

^GSPC (Benchmark)

YTD

-10.18%

1M

-6.92%

6M

-9.92%

1Y

5.42%

5Y*

12.98%

10Y*

9.70%

*Annualized

Monthly Returns

The table below presents the monthly returns of ARGX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20256.53%-4.65%-5.25%0.73%-3.06%
20240.02%-0.13%3.61%-4.63%-1.19%15.91%19.96%0.28%4.79%8.16%5.16%-0.25%61.66%
20230.90%-4.25%1.79%4.11%0.21%0.26%29.44%-0.39%-2.16%-4.49%-4.04%-15.57%0.42%
2022-23.11%6.85%9.59%-8.88%7.65%22.50%-3.87%3.75%-6.57%9.88%2.59%-4.81%8.18%
2021-0.36%12.85%-16.72%4.11%-2.69%7.91%1.12%8.73%-8.77%-0.01%-7.53%25.42%19.08%
2020-10.11%-2.02%-6.83%11.20%49.70%2.70%2.18%0.50%13.51%-5.48%15.59%2.53%83.21%
201910.45%25.61%-6.34%2.59%-3.47%14.52%-0.79%-6.41%-13.31%7.46%20.90%8.42%67.09%
201822.87%-1.22%4.97%8.93%8.99%-13.24%9.52%3.39%-19.17%5.50%20.95%-0.72%52.15%
2017-9.35%1.73%-1.13%-0.33%8.18%1.37%39.70%97.19%174.52%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 93, ARGX is among the top 7% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ARGX is 9393
Overall Rank
The Sharpe Ratio Rank of ARGX is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of ARGX is 9393
Sortino Ratio Rank
The Omega Ratio Rank of ARGX is 9090
Omega Ratio Rank
The Calmar Ratio Rank of ARGX is 9292
Calmar Ratio Rank
The Martin Ratio Rank of ARGX is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for argenx SE (ARGX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ARGX, currently valued at 1.81, compared to the broader market-2.00-1.000.001.002.003.00
ARGX: 1.82
^GSPC: 0.24
The chart of Sortino ratio for ARGX, currently valued at 2.60, compared to the broader market-6.00-4.00-2.000.002.004.00
ARGX: 2.60
^GSPC: 0.47
The chart of Omega ratio for ARGX, currently valued at 1.32, compared to the broader market0.501.001.502.00
ARGX: 1.32
^GSPC: 1.07
The chart of Calmar ratio for ARGX, currently valued at 1.73, compared to the broader market0.001.002.003.004.00
ARGX: 1.73
^GSPC: 0.24
The chart of Martin ratio for ARGX, currently valued at 10.81, compared to the broader market-5.000.005.0010.0015.0020.00
ARGX: 10.81
^GSPC: 1.08

The current argenx SE Sharpe ratio is 1.82. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of argenx SE with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
1.82
0.24
ARGX (argenx SE)
Benchmark (^GSPC)

Dividends

Dividend History


argenx SE doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-11.25%
-14.02%
ARGX (argenx SE)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the argenx SE. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the argenx SE was 38.20%, occurring on Dec 20, 2023. Recovery took 177 trading sessions.

The current argenx SE drawdown is 11.25%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-38.2%Jul 24, 2023106Dec 20, 2023177Sep 5, 2024283
-36.29%Jun 13, 201884Oct 10, 201819Nov 6, 2018103
-34.13%Jan 10, 202045Mar 16, 202049May 26, 202094
-33.09%Feb 12, 2021242Jan 27, 2022108Jul 5, 2022350
-29.18%Jul 19, 201957Oct 8, 201940Dec 4, 201997

Volatility

Volatility Chart

The current argenx SE volatility is 13.37%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
13.37%
13.60%
ARGX (argenx SE)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of argenx SE over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how argenx SE is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
ARGX: 46.7
The chart displays the Price-to-Earnings (P/E) ratio for ARGX, comparing it with other companies in the Biotechnology industry. Currently, ARGX has a P/E ratio of 46.7. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
2.04.06.08.010.0
ARGX: 0.0
The chart shows the Price/Earnings to Growth (PEG) ratio for ARGX compared to other companies in the Biotechnology industry. ARGX currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
2.04.06.08.010.0
ARGX: 16.2
This chart shows the Price-to-Sales (P/S) ratio for ARGX relative to other companies in the Biotechnology industry. Currently, ARGX has a P/S ratio of 16.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
ARGX: 6.6
The chart illustrates the Price-to-Book (P/B) ratio for ARGX in comparison with other companies in the Biotechnology industry. Currently, ARGX has a P/B value of 6.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for argenx SE.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab